About Bexarotene
            
            Class: | Antineoplastic agent, Retinoid  
Use: | Treatment of cutaneous manifestations of T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy  
Adult dose: | Initial dose of 300 mg/m²/day orally for the first 14 days, then may be adjusted based on clinical response and tolerability; maximum dose typically does not exceed 600 mg/m²/day  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended  
Side effects: | Common
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Retinoid
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of cutaneous manifestations of T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Cephalon, UNITED KINGDOM
                    
                    
                    Package Size
                    100's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 11557.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 300 mg/m²/day orally for the first 14 days, then may be adjusted based on clinical response and tolerability; maximum dose typically does not exceed 600 mg/m²/day
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include hyperlipidemia, hypothyroidism, fatigue, nausea, vomiting, diarrhea, and skin rash
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with a known hypersensitivity to Bexarotene or any component of the formulation; caution in patients with liver impairment
         
        
        
            
                Important Warnings
            
            Important safety warnings include the risk of severe hyperlipidemia and hypothyroidism; regular monitoring of lipid levels and thyroid function is recommended during treatment; potential for teratogenic effects; women of childbearing potential should use effective contraception during treatment and for at least 1 month after discontinuation
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.